^a Tested in dextrose 5%.

^b Tested in sodium chloride 0.9%.

^c Refer to Appendix for the composition of parenteral nutrition solutions. TPN indicates a 2-in-1 admixture.

^d Sulbactam component. Sulbactam in a 1:1 fixed-ratio concentration with durlobactam.

^e Tested in either dextrose 5% or in sodium chloride 0.9%, but the report did not specify which solution.

^f Tested in a 1:1 mixture of (1) dextrose 5% and dextrose 5% in sodium chloride 0.45% with and without potassium chloride 20 mEq/L and also in (2) dextrose 10% in sodium chloride 0.45% with and without potassium chloride 20 mEq/L.

^g Trimethoprim component. Trimethoprim in a 1:5 fixed-ratio concentration with sulfamethoxazole.

^h Tested in both dextrose 5% and sodium chloride 0.9%.

ⁱ Ceftolozane component. Ceftolozane in a 2:1 fixed-ratio concentration with tazobactam.

^j Meropenem component. Meropenem in a 1:1 fixed-ratio concentration with vaborbactam.

^k Ceftazidime component. Ceftazidime in a 4:1 fixed-ratio concentration with avibactam.

^l Tested in dextrose 5%, sodium chloride 0.9%, and Ringer’s injection, lactated.

^m Test performed using the formulation WITH edetate disodium.

ⁿ Tested with fentanyl citrate (TER) 0.05 mg/mL.

^o Tested with remifentanil HCl (DSC) 0.1 mg/mL.

^p Tested with remimazolam besylate (MUN) 5 mg/mL.

^q Tested in sterile water for injection.